Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia

Published:2014-09-19 Issue:2 Volume:94 Page:297-306
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Boztug Heidrun, ,Zecca Marco,Sykora Karl-Walter,Veys Paul,Lankester Arjan,Slatter Mary,Skinner Roderick,Wachowiak Jacek,Pötschger Ulrike,Glogova Evgenia,Peters Christina

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2196-8.pdf

Reference58 articles.

1. Peters C, Schrauder A, Schrappe M et al (2005) Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts. Bone Marrow Transplant 35(Suppl 1):S9–11

2. Schrappe M, Reiter A, Zimmermann M et al (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 14:2205–2222

3. Pulsipher MA, Peters C, Pui CH (2011) High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant? Biol Blood Marrow Transplant 17:S137–148

4. Eckert C, Henze G, Seeger K et al (2013) Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group. J Clin Oncol 31:2736–2742

5. Schrauder A, von Stackelberg A, Schrappe M, Cornish J, Peters C (2008) Allogeneic hematopoietic SCT in children with all: current concepts of ongoing prospective SCT trials. Bone Marrow Transplant 41(Suppl 2):S71–74

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Mucositis and Nutritional Status in Children Who Underwent Hematopoietic Cell Transplantation: A Comparison Between Nonmalignant and Malignant Primary Diseases;Pediatric Transplantation;2024-07-08

2. Improvement of survival after hematopoietic stem cell transplantation and trends at a pediatric transplantation center; a three‐decade journey;Pediatric Transplantation;2024-01-26

3. Acute Lymphoblastic Leukaemia in Children and Adolescents;The EBMT Handbook;2024

4. Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts;Transplantation and Cellular Therapy;2023-12

5. Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC);Transplantation and Cellular Therapy;2023-11